Prevention of fungal vaginitis / bacterial vaginosis comparing two new devices: tampons releasing a LN® probiotic mix and tampons releasing chlorhexidine vs. neutral tampons (placebo). Open preliminary randomized prospective clinical trial

/in /da

Autore: F. Anglana, C. Oliva, G. Morgante, F. Pagano

Pelvic Inflammatory Disease and Sexually Transmitted Diseases, A.C.O. San Filippo Neri, Rome. Division of Obstetrics and Gynecology A.C.O. San Filippo Neri – Rome. Department of Pediatrics, Obstetrics and Reproductive Medicine Obstetrical and Gynecological Clinic of the University of Studies of Siena. Department of Experimental Medicine, Second University of Naples

Potrebbero interessarti
Il compartimento microbiologico urogenitale femminile con focus sul Lactobacillus paracasei subsp. paracasei F19
Vaginal Microbiome and Epithelial Gene Array in Post- Menopausal Women with Moderate to Severe Dryness
Effectiveness of oral administration of Lactobacillus paracasei subsp. paracasei F19 in conjunction with use of a vaginal tampon containing LN® probiotic mixture (L. gasseri LN40, L. fermentum LN99, L. casei subsp. rhamnosus LN113) in the treatment of vaginosis
Dalla medicina di genere alla medicina genere-specifica
La nuove prospettive della Medicina di Genere in Ginecologia.
Synbiotic Modulation of Gut Flora Effects on Minimal Hepatic Encephalopathy in Patients With Cirrhosi
Lactic acid bacteria colonization and clinical outcome after probiotic supplementation in conventionally treated bacterial vaginosis and vulvovaginal candidiasis.
Gastrointestinal symptoms before and during menses in healthy women